Close Menu

NEW YORK – As the broader stock market tanked last week amid fears of a coronavirus pandemic, the shares of companies in the genomics research tools and molecular diagnostics markets were not immune to the selloff.

The awful week for publicly traded stocks pulled the GenomeWeb Index down 7 percent for the month of February. In comparison, the Dow Jones Industrial Average fell 11 percent, the Nasdaq declined 8 percent, and the Nasdaq Biotech Index only dropped 2 percent month over month.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.